Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein ...

Detailed price information for Rakovina Therapeutics Inc (RKV-X) from The Globe and Mail including charting and trades.

Going gray is an inevitable, and for many, undesirable, part of aging, but health-wise, it’s no bad thing – it could reflect ...

The Company has established a pipeline of distinctive DNA-damage response inhibitors with the goal of advancing ... Although the company has attempted to identify important factors that could cause ...

Reviewers viewed the targeting of TFAM as innovative and the study's conclusions as potentially important (especially the effects on inflammation). However, the lack of evidence for a direct effect of ...

Outstanding measure of efficacy relative to high-risk cancers with limited treatment optionsCHICAGO, (GLOBE NEWSWIRE) -- MAIA ...

Dermatologists share the most common—and surprising—rosacea triggers, from skincare culprits to foods, weather, and other lifestyle factors.

In a new study led by researchers at Children's Hospital of Philadelphia (CHOP) and the Perelman School of Medicine at the University o ...

Researchers from several universities and officials from federal and local public health agencies will gather tonight to update the community on ongoing studies into the health and environmental impac ...

WASHINGTON (AP) — President Donald Trump is calling on the Senate to scrap the filibuster, so that the Republican majority ...